<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
MGC Pharmaceuticals Ltd is boosted by a new landmark as CannEpil+, a Cannabis based treatment for epilepsy, has been approved for import by the UK authorities. An import permit was issued by the Medicines and Healthcare products Regulatory Agency, and, the award was enabled by MGC’s UK distribution and clinical access partner Elite Pharmaco.
...read full article on Proactive Investors
